mAbxience | CDMO
CONTRACT DEVELOPMENT AND MANUFACTURING COMPANY
Independent CDMO platform with 40+ years of experience within Insud Pharma Group, providing clients with end-to-end solutions.
mAbxience CDMO business offers a complete service from small R&D and clinical batches to full commercial production:
- Process & analytical development infrastructure from process development to optimization and scale up.
- Robust processes following cGMP manufacturing guidelines.
- Constantly expanding global capacities and capabilities with flexibility provided from 3L to 4,000L single-use bioreactors.
- Internal and external Technology Transfer expertise.
- Extensive knowledge of both fed batch and perfusion technology.
- Cell line development capabilities.
- Examples of product offerings include monoclonal antibodies, cytokines, chimeric proteins, recombinant hormones, adenoviral or bacilovirus vaccines, and other glycosylated recombinant proteins.